Clinical trial
Fluvastatin in the Therapy of Acute Coronary Syndrome
NCT00171275 is registered in ClinicalTrials.gov with Novartis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fluvastatin in the Therapy of Acute Coronary Syndrome
- Lead sponsor
- Novartis
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2003
- Completion date
- Not reported
- Enrollment
- 1,000
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.